NCT02481856View on ClinicalTrials.gov

A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

PHASE2CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Allergic Rhinoconjunctivitis
Interventions
DRUG

SQ tree SLIT-tablet

DRUG

Placebo

Trial Locations (1)

ON, L4W 1A4

Inflamax Research Inc., Mississauga

All Listed Sponsors
collaborator

Inflamax Research Incorporated

INDUSTRY

lead

ALK-Abelló A/S

INDUSTRY

NCT02481856 - A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber | Biotech Hunter | Biotech Hunter